Literature DB >> 11857635

The cryptophycins: their synthesis and anticancer activity.

MariJean Eggen1, Gunda I Georg.   

Abstract

The cryptophycins are a unique family of 16-membered macrolide antimitotic agents isolated from the cyanobacteria Nostoc sp. Their molecular target is tubulin protein wherein they are the most potent known stabilizers of microtubule dynamics and depolymerize microtubules at higher concentrations. They also deactivate the Bcl2 protein and produce apoptotic response much more quickly and at considerably lower concentrations than clinically utilized compounds. The presence of several amide and ester linkages within the cryptophycin core provides access to very convergent total synthetic approaches. Likewise, the modularity of the structure renders their synthesis amenable to structure-activity studies in several regions of the molecule. The in vivo hydrolytic instability of the C5 ester was a key obstacle to the successful identification of a clinical candidate. This problem was ameliorated by increased substitution at C6 as in the presence of gem-dimethyl substitution in the clinical candidate, cryptophycin-52. Copyright 2002 John Wiley & Sons, Inc. Med Res Rev, 22, No. 2, 85-101, 2002; DOI 10.1002/med.10002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857635     DOI: 10.1002/med.10002

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  15 in total

1.  Efficient, divergent synthesis of cryptophycin unit A analogues.

Authors:  Kyle L Bolduc; Scott D Larsen; David H Sherman
Journal:  Chem Commun (Camb)       Date:  2012-05-22       Impact factor: 6.222

2.  Chemoenzymatic synthesis of cryptophycin anticancer agents by an ester bond-forming non-ribosomal peptide synthetase module.

Authors:  Yousong Ding; Christopher M Rath; Kyle L Bolduc; Kristina Håkansson; David H Sherman
Journal:  J Am Chem Soc       Date:  2011-08-25       Impact factor: 15.419

Review 3.  Frontiers and opportunities in chemoenzymatic synthesis.

Authors:  Jonathan D Mortison; David H Sherman
Journal:  J Org Chem       Date:  2010-11-05       Impact factor: 4.354

4.  Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.

Authors:  Yousong Ding; Wolfgang H Seufert; Zachary Q Beck; David H Sherman
Journal:  J Am Chem Soc       Date:  2008-03-26       Impact factor: 15.419

5.  Functional and structural characterization of a cation-dependent O-methyltransferase from the cyanobacterium Synechocystis sp. strain PCC 6803.

Authors:  Jakub Grzegorz Kopycki; Milton T Stubbs; Wolfgang Brandt; Martin Hagemann; Andrea Porzel; Jürgen Schmidt; Willibald Schliemann; Meinhart H Zenk; Thomas Vogt
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

6.  A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs.

Authors:  Jennifer J Schmidt; Yogan Khatri; Scott I Brody; Catherine Zhu; Halina Pietraszkiewicz; Frederick A Valeriote; David H Sherman
Journal:  ACS Chem Biol       Date:  2020-02-03       Impact factor: 5.100

7.  Advances in the chemistry of β-lactam and its medicinal applications.

Authors:  Anushree Kamath; Iwao Ojima
Journal:  Tetrahedron       Date:  2012-08-07       Impact factor: 2.457

8.  2-Phenyl-tetrahydropyrimidine-4(1H)-ones--cyclic benzaldehyde aminals as precursors for functionalised beta-amino acids.

Authors:  Markus Nahrwold; Arvydas Stoncius; Anna Penner; Beate Neumann; Hans-Georg Stammler; Norbert Sewald
Journal:  Beilstein J Org Chem       Date:  2009-09-14       Impact factor: 2.883

9.  Total synthesis and biological evaluation of fluorinated cryptophycins.

Authors:  Christine Weiß; Tobias Bogner; Benedikt Sammet; Norbert Sewald
Journal:  Beilstein J Org Chem       Date:  2012-11-23       Impact factor: 2.883

Review 10.  Potential applications of algae in biochemical and bioenergy sector.

Authors:  Kanika Arora; Pradeep Kumar; Debajyoti Bose; Xiangkai Li; Saurabh Kulshrestha
Journal:  3 Biotech       Date:  2021-05-24       Impact factor: 2.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.